이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2008. 8. 6.1 분 읽기
Oral Dosage Form New Animal Drugs; Amprolium
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Phibro Animal Health. The supplemental NADA provides for label revisions associated with a previous change of sponsorship and other minor changes for amprolium concentrate solution to make medicated drinking water for chickens and turkeys for the treatment of coccidiosis. The product approval is being codified for the first time.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →